OOIR: Observatory of International Research

Papers

(The H4-Index of JACC-Cardiovascular Interventions is 56. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-01-01 to 2026-01-01.)

Article	Citations
Optimizing the Use of Artificial Intelligence in Cardiology in 2024	139
Permanent Pacemaker After TAVR	131
Transcatheter Aortic Valve in Failing Mechanical Aortic Valve	127
100.07 ABSTRACT WITHDRAWN	125
200.13 Trends of Pulmonary Embolism and Cancer Related Mortality in the United States From 1999-2020	122
100.40 CTO-PCI in Patients With and Without Diabetes Mellitus: Insights From a University Hospital in Argentina	116
300.16 Serum Copeptin Level as a Predictor of One-Year Mortality After Acute Decompensated Heart Failure Hospitalization	114
Transcatheter Aortic Valve Replacement in Patients With Bicuspid Aortic Stenosis	104
Should Postprocedure Anticoagulation Be Routinely Needed in Acute STEMI Patients Undergoing Primary PCI?	100
Short Duration of DAPT vs De-Escalation After Percutaneous Coronary Intervention for Acute Coronary Syndromes	94
Should CFR Be Routinely Measured in the Cath Lab?	89
Novel Approach to Percutaneous Closure of an RCA Fistula via the Coronary Sinus	88
Half-Dose DOAC After Watchman Implantation	88
Multiple Coronary Aneurysms Post–Drug-Eluting Stenting	86
Percutaneous Removal of a Left Atrial Papillary Fibroelastoma Using AlphaVac Aspiration Thrombectomy	85
CRT-400.03 Effect of High-intensity Statin Therapy on Atherosclerosis in Non-Infarct-Related Coronary Arteries (IBIS-4): A Machine Learning-Based Analysis of IVUS	84
Balloon-Expandable Valve for Treatment of Self-Expanding Supra-Annular Valve Failure	84
CRT-700.68 Long QT Syndrome in Transcatheter Aortic Valve Replacement: Complications and Prognostic Outcomes	83
Improving Cardiac Outcomes Among Patients With Severe Chronic Kidney Disease	83
CRT-700.79 Short- and Long-Term Outcomes in Symptomatic Patients With Hypertrophic Obstructive Cardiomyopathy Undergoing Alcohol Septal Ablation: Experience in a Referral Center	82
A Floating Coil	81
INSIDE THIS ISSUE	80
CRT-600.10 Combining VA-ECMO and Impella (EC-Pella) Before Reperfusion Mitigates Left Ventricular Loading and Injury Due to VA-ECMO in Acute Myocardial Infarction	78
Inside This Issue	76
Sex-Specific Care After Primary Angioplasty	76

Bail-Out Emergency Treatment of Left Atrial Perforation After Appendage Occlusion Using Percutaneous Vascular Plug Device	76
Prominent Collateral Vessels in Pulmonary Vein Occlusion	73
Reply	72
Right Ventricular–Pulmonary Arterial Coupling	72
Distal Target Vessel Characterization in CTO Vessels	71
TAVR and COVID-19	70
Editorial Board	68
Cardiac Resynchronization Therapy Complicated by an Indirect Annuloplasty Device Blocking Targeted Side Branch	67
CRT-100.20 Radiation Doses Using a Novel Radiation Protection System: A Single-Center Prospective Observational Study	67
Full Issue PDF	66
CRT-100.9 Comparison for Use of Telmisartan and Candesartan on 3-Year Clinical Outcomes After Acute Myocardial Infarction in Korean Population: From the Korea Acute Myocardial Infarction Registry-Nati	66
CRT-300.05 Atherectomy Use Is Associated With Lower Rates of Major Adverse Limb Events Among Adults Undergoing Femoropopliteal Interventions: Insights From the Vascular Quality Initiative Registry	64
Contrast-Induced Encephalopathy After Diagnostic Coronary Angiography	63
CRT-700.38 Racial Disparities in Transcatheter Aortic Valve Replacement in Japanese Compared With Western Patients	62
400.2 Factors Related with Concordance and Discordance Between Quantitative Flow Ratio and Myocardial Perfusion Scintigraphy	61
300.08 Effects of Ultrasound-Based Renal Denervation on Weight Gain and Waist Circumference	60
100.37 Procedural and Clinical Outcomes After Intravascular Lithotripsy in Patients Undergoing Percutaneous Coronary Intervention for In-Stent Restenosis	60
A Word of Caution Regarding Postdilatation of Self-Expanding Valves for Paravalvular Leak	60
500.10 From Chest Pain to Coronary Functional Testing: Clinical and Economic Impact of Coronary Microvascular Dysfunction	59
Changing Clinical Indications for Femoropopliteal Revascularization From 2016 to 2023	59
CRT-400.09 Impact of Statin on Non-Culprit Coronary Lesions and Adverse Events: Insight From LRP Study	59
Tailoring TAVR System Design to Patient Characteristics and Needs	58
Advantages and Limitations of Retro- and Prospective Comparative TAVR Studies	58
Atrial Fibrillation Post-PFO Closure	58
Upper Extremity Superficial Venous Access in Ultrasound-Assisted Thrombolysis for Acute Pulmonary Embolism	58
Transcatheter Heart Valves Devices for Native Aortic Valve Regurgitation	58
Mismatch Between Residual Mitral Regurgitation and Left Atrial Pressure Predicts Prognosis After Transcatheter Edge-to-Edge Repair	57
Tricuspid Regurgitation and Pulmonary Hypertension	57
MitraClip vs PASCAL for Degenerative Mitral Regurgitation	57
Commissural Alignment After Balloon-Expandable Transcatheter Aortic Valve Replacement Is Associated With Improved Hemodynamic Outcomes	57
Early Risk of Major Adverse Limb Events Following Lower Extremity Revascularization in the VOYAGER-PAD Trial	56
Drug-Coated Balloons for Percutaneous Coronary Intervention	56
Curtain Up for LAMPOON in Transcatheter Mitral Valve Replacement!	56
Call to ACTION	56
Reply	56